Humanigen (HGEN) - Earnings

Earnings in 2023 (TTM): -HK$0.41 Billion

According to Humanigen's latest financial reports the company's current earnings are HK$1.69 Million. In 2022 the company made an earning of -HK$0.53 Billion, an increase over its 2021 earnings that were of -HK$1.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Humanigen from 2012 to 2023

Annual earnings

Year	Earnings	Change
2023 (TTM)	-HK$0.41 Billion	-23.6%
2022	-HK$0.53 Billion	-71.07%
2021	-HK$1.83 Billion	165.75%
2020	-HK$0.69 Billion	886.01%
2019	-HK$69.73 Million	-19.79%
2018	-HK$86.93 Million	-41.09%
2017	-HK$0.15 Billion	-29.59%
2016	-HK$0.21 Billion	-22.15%
2015	-HK$0.27 Billion	-6.11%
2014	-HK$0.29 Billion	-10.04%
2013	-HK$0.32 Billion	74.13%
2012	-HK$0.19 Billion

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Novocure NVCR	-HK$1 Billion	146.99%	Jersey
Novavax NVAX	HK$2.92 B	-829.10%	🇺🇸 USA
Organovo ONVO	-HK$19.38 Million	-95.17%	🇺🇸 USA
Orchard Therapeutics ORTX	-HK$0.57 Billion	42.05%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Humanigen (HGEN)

Earnings in 2023 (TTM): -HK$0.41 Billion